The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Alzheimer's & Dementia

• Publication date

  2015-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jalz.2014.12.009PMID 25936935PMCID PMC4627856
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis.

  2014influential reference
• Triggering receptor expressed on myeloid cells 2 variant is rare in late-onset Alzheimer's disease in Han Chinese individuals.

  2014cited by this paper
• Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.

  2014cited by this paper
• Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease

  2014cited by this paper
• Lack of Genetic Association Between TREM2 and Late-Onset Alzheimer's Disease in a Japanese Population

  2014cited by this paper
• Heterozygous TREM2 mutations in frontotemporal dementia.

  2014cited by this paper
• R47H TREM2 variant increases risk of typical early‐onset Alzheimer's disease but not of prion or frontotemporal dementia

  2014cited by this paper
• Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease

  2014cited by this paper
• The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk

  2014cited by this paper
• Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.

  2014cited by this paper
• TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis.

  2014cited by this paper
• TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease

  2013influential reference
• TREM2 and neurodegenerative disease.

  2013influential reference
• Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease.

  2013cited by this paper
• GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.

  2013influential reference
• Assessment of TREM2 rs75932628 association with Alzheimer's disease in a population-based sample: the Cache County Study.

  2013cited by this paper
• TREM2 R47H Variant as a Risk Factor for Early-Onset Alzheimer's Disease

  2013cited by this paper
• Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

  2013cited by this paper
• TREM2 variants in Alzheimer's disease.

  2013influential reference
• TREM2 and neurodegenerative disease.

  2013cited by this paper
• Distinguishing true from false positives in genomic studies: p values

  2013cited by this paper
• TREM2 is associated with the risk of Alzheimer's disease in Spanish population.

  2013cited by this paper
• TREM2 and neurodegenerative disease.

  2013cited by this paper
• TREM2 and neurodegenerative disease.

  2013cited by this paper
• TREM2 and neurodegenerative disease.

  2013influential reference
• TREM2 and neurodegenerative disease.

  2013cited by this paper
• Variant of TREM2 associated with the risk of Alzheimer's disease.

  2013influential reference
• TREM 2 and Neurodegenerative Disease

  2013cited by this paper
• Integrative Annotation of Variants from 1092 Humans: Application to Cancer Genomics

  2013cited by this paper
• Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways

  2012cited by this paper
• Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database

  2012cited by this paper
• Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement.

  2012cited by this paper
• The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels.

  2011cited by this paper
• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• Towards unveiling the genetics of neurodegenerative diseases.

  2011cited by this paper
• Quantifying Selective Reporting and the Proteus Phenomenon for Multiple Datasets with Similar Bias

  2011cited by this paper
• Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

  2010influential reference
• Bayes factors in complex genetics

  2010cited by this paper
• Risk of Parkinson’s disease after hospital contact for head injury: population based case-control study

  2008cited by this paper
• Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

  2007cited by this paper
• A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints

  2006cited by this paper
• Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype.

  2002cited by this paper
• Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology committee on Research.

  1999cited by this paper
• Diagnostic criteria for Parkinson disease.

  1999cited by this paper
• Mild Cognitive Impairment Clinical Characterization and Outcome

  1999cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• Alzheimer’s Dementia

  1985cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper

• TREM2 and microglial immunity in Alzheimer's disease: mechanisms, genetics, and therapeutic opportunities.

  2026cites this paper
• TREM2‐apoE3 interactions and Alzheimer's disease: Molecular and structural insights and effects of TREM2 R47H and apoE4 variants

  2025cites this paper
• Study on the Pharmacological Efficacy and Mechanism of Dual-Target Liposome Complex AD808 Against Alzheimer’s Disease

  2025cites this paper
• TREM2 hit discovery using temperature-related intensity change (TRIC) technology: A proof-of-concept high-throughput screening approach

  2025cites this paper
• Comparing Alzheimer's genes in African, European, and Amerindian induced pluripotent stem cell–derived microglia

  2025cites this paper
• TREM2 risk variants and associated endophenotypes in alzheimer’s disease

  2025cites this paper
• Immune cell metabolic dysfunction in Parkinson’s disease

  2025cites this paper
• Distinct factors drive the progression of tau pathology in Alzheimer's disease

  2025cites this paper
• The Genetic Background of the Immunological and Inflammatory Aspects of Progressive Supranuclear Palsy

  2025cites this paper
• Unraveling the Immune Puzzle: Role of Immunomodulation in Alzheimer’s Disease

  2025cites this paper
• Comparative analysis of neuroinflammatory pathways in Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis: insights into similarities and distinctions

  2025cites this paper
• Plasma soluble TREM2 is associated with plasma pTau-181 and pTau-231 in cognitively normal older adults at risk of Alzheimer's disease

  2025cites this paper
• TREM2 Hit Discovery Using TRIC Technology: A Proof-of-Concept High-Throughput Screening Approach

  2025cites this paper
• Non-canonical Pathways Associated to Amyloid Beta and Tau Protein Dyshomeostasis in Alzheimer's disease: a narrative review.

  2024cites this paper
• Gene expression and chromatin accessibility comparison in iPSC-derived microglia in African, European, and Amerindian genomes in Alzheimer’s patients and controls

  2024cites this paper
• Biofluid biomarkers for Alzheimer’s disease

  2024cites this paper
• TREM2 in Alzheimer's disease: Structure, function, therapeutic prospects, and activation challenges.

  2024cites this paper
• Modulation of the central nervous system immune response and neuroinflammation via Wnt signaling in health and neurodegenerative diseases

  2024cites this paper
• Artificial intelligence for dementia drug discovery and trials optimization

  2023cites this paper
• Neuroimaging Genetics and Network Analysis in Alzheimer's Disease Dementia.

  2023cites this paper
• Galectin‐3 is upregulated in frontotemporal dementia patients with subtype specificity

  2023cites this paper
• The association of R47H variant in the TREM2 gene and genetic susceptibility to Alzheimer's disease in Serbian population

  2023cites this paper
• Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation

  2023cites this paper
• Implication of tau propagation on neurodegeneration in Alzheimer’s disease

  2023cites this paper
• Allogenic microglia replacement: A novel therapeutic strategy for neurological disorders

  2023influential citation
• Novel therapeutic approaches for motor neuron disease.

  2023cites this paper
• Heparan Sulfate in Alzheimer's Disease: Aberrant expression and functions in molecular pathways related to amyloid-β metabolism.

  2023cites this paper
• The innate immune response in tauopathies

  2023cites this paper
• Recent Advancements in the Treatment of Alzheimer's Disease: A Multitarget-directed Ligand Approach.

  2023cites this paper
• Molecular recognition of the interaction between ApoE and the TREM2 protein

  2022cites this paper
• The Role of Inflammasomes in the Pathogenesis of Neurodegenerative Diseases

  2022cites this paper
• Glycolytic metabolism supports microglia training during age-related neurodegeneration

  2022cites this paper
• A Trem2R47H mouse model without cryptic splicing drives age- and disease-dependent tissue damage and synaptic loss in response to plaques

  2022cites this paper
• Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies

  2022cites this paper
• Role of caspases, apoptosis and additional factors in pathology of Alzheimer's disease

  2022cites this paper
• Role of TREM2 in the Development of Neurodegenerative Diseases After Traumatic Brain Injury

  2022cites this paper
• Triggering receptor expressed on myeloid cells 2 deficiency exacerbates injury-induced inflammation in a mouse model of tauopathy

  2022cites this paper
• Manipulation of the diet–microbiota–brain axis in Alzheimer’s disease

  2022cites this paper
• TREM2 R47H variant and risk for Alzheimer’s disease: assessment in a Greek population and updated meta-analysis

  2022cites this paper
• TREM2 coding variants in Slovak Alzheimer's disease patients.

  2022cites this paper
• Lack of association between TREM2 rs75932628 variant and amyotrophic lateral sclerosis

  2021cites this paper
• Family-based exome sequencing identifies RBM45 as a possible candidate gene for frontotemporal dementia and amyotrophic lateral sclerosis.

  2021cites this paper
• The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer’s Disease

  2021cites this paper
• Region-based analysis of rare genomic variants in whole-genome sequencing datasets reveal two novel Alzheimer’s disease-associated genes: DTNB and DLG2

  2021cites this paper
• Reassessment of Pioglitazone for Alzheimer’s Disease

  2021cites this paper
• Alzheimer’s Disease Genetics: A Dampened Microglial Response?

  2021cites this paper
• TrendyGenes, a computational pipeline for the detection of literature trends in academia and drug discovery

  2021cites this paper
• Microglial TREM2 at the Intersection of Brain Aging and Alzheimer’s Disease

  2021cites this paper
• TREM2 Limits Progression of Deficits and Spreading of Tau Pathology in Mice

  2021cites this paper
• Myelin, cPLA2, and Azithromycin: Modulation of Macrophage Activation in Spinal Cord Injury Inflammation

  2021cites this paper
• Advances in Genetics and Epigenetic Alterations in Alzheimer’s Disease: A Notion for Therapeutic Treatment

  2021cites this paper
• Biomarkers used in Alzheimer's Disease diagnosis, treatment, and prevention.

  2021cites this paper
• Targeting TREM2 for Parkinson’s Disease: Where to Go?

  2021cites this paper
• Early-Onset Alzheimer’s Disease: What Is Missing in Research?

  2021cites this paper
• Glial cells and adaptive immunity in frontotemporal dementia with tau pathology.

  2021cites this paper
• Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives

  2021cites this paper
• Insight into the genetic etiology of Alzheimer's disease: A comprehensive review of the role of rare variants

  2021cites this paper
• Role of triggering receptor expressed on myeloid cells 2 (TREM2) in neurodegenerative dementias

  2021cites this paper
• Neurodegenerative Disease Risk in Carriers of Autosomal Recessive Disease

  2021cites this paper
• Review: Microglia in motor neuron disease

  2020cites this paper
• Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease

  2020cites this paper
• AD-linked R47H-TREM2 mutation induces disease-enhancing proinflammatory microglial states in mice and humans

  2020cites this paper
• Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes

  2020cites this paper
• Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use

  2020cites this paper
• Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies

  2020cites this paper
• Danger-Sensing/Patten Recognition Receptors and Neuroinflammation in Alzheimer’s Disease

  2020cites this paper
• Review: Microglia in motor neuron disease Neuropathology and Applied Neurobiology Review: Microglia in motor neuron disease

  2020cites this paper
• Differential role of triggering receptors expressed on myeloid cells 2 R47H in 3 neurodegenerative diseases based on a systematic review and meta-analysis

  2020influential citation
• West Nile Virus-Induced Neurologic Sequelae—Relationship to Neurodegenerative Cascades and Dementias

  2020cites this paper
• PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment

  2020cites this paper
• Assessment of TREM2 rs75932628 variant’s association with Parkinson’s disease in a Greek population and Meta-analysis of current data

  2020cites this paper
• Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration.

  2020cites this paper
• A rare heterozygous TREM2 coding variant identified in familial clustering of dementia affects an intrinsically disordered protein region and function of TREM2

  2019cites this paper
• Human Mutation

  2019cites this paper
• Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk.

  2019cites this paper
• A Candidate Regulatory Variant at the TREM Gene Cluster Confer Alzheimer’s Disease Risk by Modulating Both Amyloid-β Pathology and Neuronal Degeneration

  2019cites this paper
• TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis

  2019cites this paper
• Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis.

  2019cites this paper
• Biopsychosocial reserves and dementia: Identifying life span protective factors

  2019cites this paper
• Frequency of the TREM2 R47H Variant in Various Neurodegenerative Disorders

  2019cites this paper
• Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease

  2019cites this paper
• Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis

  2019cites this paper
• Immune Signaling in Neurodegeneration.

  2019cites this paper
• An update on the interactions between Alzheimer's disease, autophagy and inflammation.

  2019cites this paper
• Do heterozygous mutations of Niemann–Pick type C predispose to late-onset neurodegeneration: a review of the literature

  2019cites this paper
• Neurodegenerative Disease–Associated Variants in TREM2 Destabilize the Apical Ligand-Binding Region of the Immunoglobulin Domain

  2019cites this paper
• Analysis of Cerebrospinal Fluid Soluble TREM2 and Polymorphisms in Sporadic Parkinson’s Disease in a Chinese Population

  2019cites this paper
• TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers

  2019cites this paper
• Microglia-neuron crosstalk: Signaling mechanism and control of synaptic transmission.

  2019cites this paper
• The rs75932628 and rs2234253 polymorphisms of the TREM2 gene were associated with susceptibility to frontotemporal lobar degeneration in Caucasian populations

  2018influential citation
• Frontotemporal Dementia and Chorea Associated with a Compound Heterozygous TREM2 Mutation

  2018cites this paper
• Precision pharmacology for Alzheimer's disease.

  2018cites this paper
• High TREM2 expression correlates with poor prognosis in gastric cancer.

  2018cites this paper
• Microglial TREM2/DAP12 Signaling: A Double-Edged Sword in Neural Diseases

  2018cites this paper
• Microglia in neurodegeneration

  2018cites this paper
• Deconstructing and targeting the genomic architecture of human neurodegeneration

  2018cites this paper
• High‐affinity interactions and signal transduction between Aβ oligomers and TREM2

  2018cites this paper
• Microglia in Alzheimer's Disease: Risk Factors and Inflammation

  2018cites this paper
• TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism

  2018cites this paper
• Association of Dopamine Beta-Hydroxylase Polymorphisms with Alzheimer’s Disease, Parkinson’s Disease and Schizophrenia: Evidence Based on Currently Available Loci

  2018cites this paper